Obesity and long-term outcomes after incident stroke: a prospective population-based cohort study.
body mass index
electronic health records
real-world evidence
stroke
stroke-obesity paradox
Journal
Journal of cachexia, sarcopenia and muscle
ISSN: 2190-6009
Titre abrégé: J Cachexia Sarcopenia Muscle
Pays: Germany
ID NLM: 101552883
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
revised:
16
08
2021
received:
04
07
2021
accepted:
05
09
2021
pubmed:
29
9
2021
medline:
29
1
2022
entrez:
28
9
2021
Statut:
ppublish
Résumé
The association between obesity, major adverse cardiovascular events (MACE), and mortality in patients with incident stroke is not well established. We assessed the relationship between body mass index (BMI) and MACE in patients with incident stroke. The population-based cohort study identified 30 702 individuals from the Clinical Practice Research Datalink (CPRD GOLD) and Hospital Episode Statistics (HES) databases from the United Kingdom. Individuals were aged ≥18 years with incident stroke between 1-1-1998 and 31-12-2017, a BMI recorded within 24 months before incident stroke, and no prior history of MACE. BMI was categorized as underweight (<18.5 kg/m At baseline, 1217 (4.0%) were underweight, 10 783 (35.1%) had a normal BMI, 10 979 (35.8%) had overweight, 5206 (17.0%) had obesity Class I, 1749 (5.7%) Class II, and 768 (2.5%) Class III. In multivariable analysis, higher BMI were associated with lower risk of subsequent MACE [overweight: HR 0.96, 95% CI 0.93-0.99)]; PVD [overweight: 0.65 (0.49-0.85); obesity Class III: 0.19 (0.50-0.77)]; cardiovascular-related death [overweight: 0.80 (0.74-0.86); obesity Class I: 0.79 (0.71-0.88); Class II: 0.80 (0.67-0.96)]; and all-cause mortality [overweight: 0.75 (0.71-0.79); obesity Class I: 0.75 (0.70-0.81); Class II: 0.77 (0.68-0.86)] when compared to those with normal BMI. The results were similar irrespective of sex, diabetes mellitus, smoking or cancer at time of incident stroke. In patients with incident stroke, overweight or obesity were associated with a more favourable prognosis for subsequent MACE, PVD, and mortality, irrespective of sex, diabetes mellitus, smoking, or cancer at baseline. As with other cohort studies, our study demonstrates an association. Randomized control trials should be considered to robustly evaluate the impact of weight management recommendations on subsequent cardiovascular outcomes in stroke survivors.
Sections du résumé
BACKGROUND
The association between obesity, major adverse cardiovascular events (MACE), and mortality in patients with incident stroke is not well established. We assessed the relationship between body mass index (BMI) and MACE in patients with incident stroke.
METHODS
The population-based cohort study identified 30 702 individuals from the Clinical Practice Research Datalink (CPRD GOLD) and Hospital Episode Statistics (HES) databases from the United Kingdom. Individuals were aged ≥18 years with incident stroke between 1-1-1998 and 31-12-2017, a BMI recorded within 24 months before incident stroke, and no prior history of MACE. BMI was categorized as underweight (<18.5 kg/m
RESULTS
At baseline, 1217 (4.0%) were underweight, 10 783 (35.1%) had a normal BMI, 10 979 (35.8%) had overweight, 5206 (17.0%) had obesity Class I, 1749 (5.7%) Class II, and 768 (2.5%) Class III. In multivariable analysis, higher BMI were associated with lower risk of subsequent MACE [overweight: HR 0.96, 95% CI 0.93-0.99)]; PVD [overweight: 0.65 (0.49-0.85); obesity Class III: 0.19 (0.50-0.77)]; cardiovascular-related death [overweight: 0.80 (0.74-0.86); obesity Class I: 0.79 (0.71-0.88); Class II: 0.80 (0.67-0.96)]; and all-cause mortality [overweight: 0.75 (0.71-0.79); obesity Class I: 0.75 (0.70-0.81); Class II: 0.77 (0.68-0.86)] when compared to those with normal BMI. The results were similar irrespective of sex, diabetes mellitus, smoking or cancer at time of incident stroke.
CONCLUSIONS
In patients with incident stroke, overweight or obesity were associated with a more favourable prognosis for subsequent MACE, PVD, and mortality, irrespective of sex, diabetes mellitus, smoking, or cancer at baseline. As with other cohort studies, our study demonstrates an association. Randomized control trials should be considered to robustly evaluate the impact of weight management recommendations on subsequent cardiovascular outcomes in stroke survivors.
Identifiants
pubmed: 34581015
doi: 10.1002/jcsm.12818
pmc: PMC8718037
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2111-2121Subventions
Organisme : Department of Health
Pays : United Kingdom
Informations de copyright
© 2021 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.
Références
J Am Coll Cardiol. 2001 Sep;38(3):789-95
pubmed: 11527635
J Am Coll Cardiol. 2013 Feb 5;61(5):553-60
pubmed: 23369419
Diabetes Care. 2017 Aug;40(8):1000-1001
pubmed: 28733375
Eur Heart J. 2013 Jan;34(4):268-77
pubmed: 23076781
BMJ Open. 2019 Aug 24;9(8):e028880
pubmed: 31446408
Stroke. 2011 Jan;42(1):30-6
pubmed: 21127299
Stroke. 2021 Jan;52(2):396-405
pubmed: 33493066
Am Heart J. 2020 Nov;229:61-69
pubmed: 32916609
JAMA Neurol. 2014 Aug;71(8):978-84
pubmed: 24886975
J Public Health (Oxf). 2014 Dec;36(4):684-92
pubmed: 24323951
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1143-1145
pubmed: 31661195
PLoS One. 2017 Mar 14;12(3):e0171334
pubmed: 28291782
N Engl J Med. 2017 Jul 6;377(1):13-27
pubmed: 28604169
BMJ. 2016 May 04;353:i2156
pubmed: 27146380
Eur Heart J. 2020 Jul 21;41(28):2668-2677
pubmed: 32402060
Chest. 2004 Apr;125(4):1205-12
pubmed: 15078726
Int J Epidemiol. 2015 Jun;44(3):827-36
pubmed: 26050254
Lancet. 2006 Aug 19;368(9536):666-78
pubmed: 16920472
Obes Res. 2004 Apr;12(4):633-45
pubmed: 15090631
Epidemiology. 2014 May;25(3):454-61
pubmed: 24608666
Ann Card Anaesth. 2019 Jan-Mar;22(1):67-72
pubmed: 30648682
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):2111-2121
pubmed: 34581015
N Engl J Med. 2010 Dec 2;363(23):2211-9
pubmed: 21121834
Heart. 2015 Oct;101(20):1631-8
pubmed: 26025084
Stroke. 2010 May;41(5):e418-26
pubmed: 20299666
Lancet Digit Health. 2019 May 20;1(2):e63-e77
pubmed: 31650125
N Engl J Med. 2021 Mar 18;384(11):989
pubmed: 33567185